Kava is not a controlled substance in the United States, and standard workplace drug panels do not target it. However, one of kava’s main active compounds, kavain, can cross-react with certain screening tests for amphetamines, potentially producing a false positive. The story gets more complicated when you factor in how long kavalactones linger in urine, the risk of contaminated kava products, and the rare situations where labs specifically look for kava.
How Kava Can Trigger a False Positive for Amphetamines
Most workplace and clinical drug screens rely on immunoassay technology, which uses antibodies designed to bind to a target drug or its metabolites. The problem is that these antibodies are not perfectly specific. They can latch onto molecules that share a similar shape with the target, producing a positive result even though the actual drug is not present. Kavain, the most abundant kavalactone in many kava preparations, has enough structural similarity to amphetamine-type compounds that it trips at least one common immunoassay platform.
A forensic toxicology investigation documented this directly. Urine samples from patients who had consumed kava tested positive on the CEDIA immunoassay for amphetamines. When the same samples were reanalyzed using gas chromatography-mass spectrometry, no amphetamine-type compounds were found. The only substance detected was kavain. The researchers went further, testing commercial kava powders and a pure kavain standard against the immunoassay. All of them cross-reacted, consistently producing falsely detected results for amphetamines.1PubMed. Kavain Interference with Amphetamine Immunoassay
This does not mean every kava drinker will fail a drug screen. The cross-reactivity depends on which immunoassay platform a lab uses, the concentration of kavain in your urine at the time of the test, and the cutoff threshold the lab applies. But if you drink kava regularly and are subject to drug testing, the risk is real enough to take seriously.
What Happens During Confirmatory Testing
A positive immunoassay result is not the final word. In virtually all regulated testing programs, a positive screen is followed by confirmatory testing using a more precise method, typically gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS). These instruments separate and identify individual molecules by their exact chemical structure rather than relying on antibody binding, so they can distinguish kavain from actual amphetamines with high confidence.
In the kavain interference study, GC-MS found no amphetamine-type compounds whatsoever in the urine samples that had screened positive.1PubMed. Kavain Interference with Amphetamine Immunoassay So if you are tested under a program that follows standard protocols, confirmatory testing should clear you. The catch is the gap between the initial screen and the confirmation result. In a workplace context, that lag can mean days of anxiety, temporary suspension, or other consequences while you wait for the lab to finish. Some rapid “point of care” tests at clinics or probation offices never go to a confirmation step at all unless you challenge the result, which puts the burden on you to request follow-up.
If you know you will be tested and you drink kava, it is worth mentioning it proactively to the testing authority or Medical Review Officer. Having the conversation before a flag appears is far easier than having it after.
How Long Kavalactones Stay in Your System
Kavain, the kavalactone most studied for its pharmacokinetics, is absorbed quickly and cleared relatively fast. Research on its disposition found that over 90 percent of a dose is eliminated within 72 hours, primarily through urine.2Drug Metabolism and Disposition. Pharmacokinetics and Disposition of the Kavalactone Kawain: Interaction with Kava Extract and Kavalactones in Vivo and in Vitro That 72-hour window is a useful rough guide, but it comes with caveats.
First, that figure comes from controlled dosing of kavain in isolation. When you drink traditional kava or take a whole-extract supplement, you are ingesting a mix of six major kavalactones plus other plant compounds. Some of these kavalactones inhibit the liver enzymes responsible for metabolizing each other, which could slow overall clearance. Second, individual factors like body fat, liver function, hydration, and how often you drink kava all influence how quickly the compounds wash out. A person who drinks several shells of kava every evening will likely accumulate kavalactones to a greater degree than someone who drinks occasionally.
As a practical estimate, occasional kava drinkers can expect most kavalactones to clear within about three days. Heavy or daily users should allow more time. No definitive study has pinned down the exact detection window for cross-reactivity with immunoassays at various use levels, so the 72-hour clearance figure is the best available benchmark rather than a guarantee.
The Risk from Contaminated Kava Products
Here is where the drug-test question takes a more alarming turn. Even if kava itself only risks a false positive, what if the product you bought is not actually pure kava? The herbal supplement market is poorly regulated, and adulteration happens. A recent laboratory analysis of products marketed as kava found that some contained kratom alkaloids that were not listed on the label. One product contained both kavalactones and mitragynine, while another contained mitragynine with no detectable kavalactones at all, meaning it was kratom mislabeled as kava entirely.3Clinical Toxicology. Unlabeled kratom alkaloids detected in products marketed as kava
Kratom (mitragynine) is not included on standard five- or ten-panel drug tests, but some expanded panels and specialized forensic screens do test for it. More importantly, kratom itself has been associated with false positives on certain immunoassays for other drug classes. The combination of unknowingly consuming kratom alkaloids through a “kava” product while also having kavalactones cross-react with an amphetamine screen creates a tangled mess for anyone trying to pass a drug test.
Sourcing matters. Buying from vendors who provide third-party certificates of analysis reduces this risk substantially. Products sold as loose kava root powder from established Pacific Island suppliers tend to be more straightforward than liquid extracts, shots, or capsules marketed with vague labeling. If a product does not tell you exactly what species and plant part it contains, treat it with suspicion.
When Labs Specifically Look for Kava
Standard drug panels do not include kavalactones, but that does not mean kava can never be identified in your system. Forensic toxicology labs can detect kavalactones when they have reason to look. This typically happens in driving-under-the-influence investigations or postmortem toxicology, not in workplace testing.
A case series involving impaired drivers in Iowa illustrates this. The drivers’ urine samples screened negative on standard immunoassay panels for common drugs of abuse. But because the drivers showed signs of impairment with no apparent cause, their samples were analyzed using LC-MS/MS and GC-MS with broader analyte targets. Those methods identified kavalactones.4PubMed. Cases of Kava Impairment in Iowa Drivers The key point is that finding kavalactones required targeted forensic analysis. A routine screen would have missed them entirely.
Kava is legal to buy and consume in the United States, so detecting kavalactones in your urine is not equivalent to detecting an illicit drug. But in a DUI context, impairment is impairment regardless of whether the substance is legal. If you drink enough kava to affect your coordination or reaction time, you can face impaired-driving charges even though no standard drug panel would flag you.
Kava’s Effects on Other Drug Metabolism
Even if kava itself does not directly show up on a drug test, it can indirectly complicate your results if you take other medications or substances. Kavalactones are potent inhibitors of several liver enzymes in the cytochrome P450 family, which are responsible for breaking down a wide range of pharmaceutical drugs. In laboratory studies, a kava extract standardized to kavalactone content significantly inhibited CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4, among others.5PubMed. Inhibition of human cytochrome P450 activities by kava extract and kavalactones A human study confirmed that kava reduced CYP2E1 activity by roughly 40 percent in living subjects.6PubMed Central. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes
Why does this matter for drug testing? If you take a prescription medication that is metabolized by one of these enzymes, drinking kava could slow that drug’s breakdown, causing it to accumulate to higher-than-expected levels in your blood and urine. For someone on a prescribed benzodiazepine or opioid, for example, this could mean unexpectedly elevated drug levels on a quantitative test, potentially raising questions about whether you are taking more than prescribed or obtaining the drug from other sources. The effect would not create a substance out of thin air, but it could shift the numbers in ways that attract scrutiny.
The practical advice here is straightforward: if you use kava and also take prescription medications that are metabolized by the liver, talk to your pharmacist or physician. The interaction potential is not theoretical; the enzyme inhibition is broad and significant.
How Kava Works in the Brain and Why It Does Not Look Like Benzodiazepines
People sometimes worry that because kava is used for relaxation and anxiety relief, it might trigger a positive result for benzodiazepines. This concern makes intuitive sense but does not hold up chemically. Research into kava’s mechanism of action shows that kavain enhances the activity of GABA-A receptors in the brain, which is the same general receptor family that benzodiazepines target. However, kavain binds at a different site on the receptor. Its effects are not blocked by flumazenil, the drug used to reverse benzodiazepine action, confirming that kavain works through a distinct binding mechanism.7PubMed Central. Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism
Because kavalactones are structurally unrelated to benzodiazepines, they do not cross-react with benzodiazepine immunoassays. The false-positive risk documented in the literature is specific to amphetamine screens, not to benzodiazepine, opioid, or cannabis panels. If your drug test includes only the standard five-panel (amphetamines, cannabinoids, cocaine, opiates, PCP), the amphetamine screen is the only one where kava has been shown to cause interference.
Cognitive Impairment and the DUI Question
Kava’s legal status sometimes gives people a false sense of security behind the wheel. While the formal evidence on kava and cognitive function is surprisingly thin, one study that tested participants in a traditional kava-drinking setting found no statistically significant differences in cognitive test performance between kava drinkers and controls over a six-hour period. Despite this, the researchers observed that the kava drinkers’ movements and speech visibly slowed as the session progressed.8PubMed. Kava drinking in traditional settings: Towards understanding effects on cognitive function
That gap between measurable cognitive performance and observable motor slowing is important. A field sobriety test administered by a police officer relies heavily on coordination, balance, and reaction time rather than on abstract cognitive tasks. Someone who can still do mental arithmetic under kava’s influence might nonetheless sway during a one-leg stand or respond slowly to a stimulus. And as the Iowa cases demonstrated, law enforcement can request forensic analysis capable of identifying kavalactones when the standard panel comes back clean but impairment is evident.
Kava bars have become increasingly common in the U.S., and many patrons drive themselves home. The responsible approach is the same as with alcohol: if you feel the effects, you should not drive. The legal system does not need to identify a specific controlled substance to charge you with impairment.
Physical Signs of Heavy Kava Use
While not directly related to urine drug testing, heavy kava consumption can leave its own detectable traces in your body. The most well-known is “kava dermopathy,” a dry, scaly skin condition that appears in people who drink large amounts regularly. It is sometimes described as resembling ichthyosis and tends to resolve after reducing intake.
More relevant from a clinical or occupational-health perspective are the liver enzyme changes associated with chronic kava use. A study of predominantly Tongan kava drinkers in Hawaii found that about two-thirds had elevated gamma-glutamyl transferase (GGT) levels, compared with roughly a quarter of non-drinkers. Alkaline phosphatase was also elevated at higher rates in the kava group.9PubMed. Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii A broader review of kava toxicity noted associations between heavy use and liver injury, as well as skin toxicity potentially linked to kava’s metabolic profile.10PubMed Central. An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava
These liver enzyme elevations would not appear on a drug screen, but they could show up in a blood panel ordered by a physician or as part of a health screening. Elevated GGT in particular is often interpreted as a sign of alcohol use, which could create a different kind of misunderstanding if the clinician is not aware of your kava habit. If your doctor orders liver function tests and you drink kava regularly, mention it. The enzyme pattern can look similar to that of chronic alcohol consumption, and the distinction matters for your care.
Kava Varieties and Kavalactone Profiles
Not all kava is the same, and the specific blend of kavalactones in your cup depends on the variety you are drinking. Kava cultivars are traditionally classified as “noble” (considered safe for daily consumption) and “non-noble” or “two-day” varieties (associated with more nausea, hangover-like effects, and potentially greater toxicity). Laboratory methods can distinguish these varieties based on their kavalactone ratios, particularly the proportions of kavain, flavokavain, and other compounds.11Journal of Food Composition and Analysis. Comparison of kava (Piper methysticum Forst.) varieties by UV absorbance of acetonic extracts and high-performance thin-layer chromatography
From a drug-testing perspective, the variety you consume could matter because kavain content varies between cultivars. A noble variety high in kavain would theoretically pose a greater false-positive risk on an amphetamine immunoassay than a variety where kavain is a smaller proportion of the total kavalactone mix. That said, no study has directly compared false-positive rates across kava cultivars, so this remains an educated inference rather than a tested conclusion. For most kava drinkers, the more practical concern is whether they are drinking a noble variety at all, since cheap supplements and extracts do not always disclose what type of kava they contain.
Countries like Vanuatu and Fiji have export standards that restrict commercial kava to noble varieties, so products traceable to those supply chains are generally more reliable. Kava sold as a generic herbal supplement without cultivar information could be anything, including non-noble varieties or a mixture of plant parts with different kavalactone concentrations.